189 related articles for article (PubMed ID: 35650243)
1. Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
Hsieh HS; Gong YN; Chi CY; Hsieh SY; Chen WT; Ku CL; Cheng HT; Lin L; Sung CM
Sci Rep; 2022 Jun; 12(1):9126. PubMed ID: 35650243
[TBL] [Abstract][Full Text] [Related]
2. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
Front Immunol; 2019; 10():1905. PubMed ID: 31474987
[TBL] [Abstract][Full Text] [Related]
4. Immune Alterations in Patients with Anti-Interferon-γ Autoantibodies.
Chruewkamlow N; Mahasongkram K; Pata S; Chaiwarith R; Salee P; Supparatpinyo K; Kasinrerk W
PLoS One; 2016; 11(1):e0145983. PubMed ID: 26727515
[TBL] [Abstract][Full Text] [Related]
5. Immunodeficiency and Autoantibodies to Cytokines.
Knight V
J Appl Lab Med; 2022 Jan; 7(1):151-164. PubMed ID: 34996092
[TBL] [Abstract][Full Text] [Related]
6. Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
Rujirachun P; Sangwongwanich J; Chayakulkeeree M
BMC Infect Dis; 2020 Mar; 20(1):232. PubMed ID: 32188404
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
8. Emerging clinical phenotypes associated with anti-cytokine autoantibodies.
Vincent T; Plawecki M; Goulabchand R; Guilpain P; Eliaou JF
Autoimmun Rev; 2015 Jun; 14(6):528-35. PubMed ID: 25633324
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and anti-cytokine autoantibodies during experimental african trypanosomiasis in mice with disrupted interferon-gamma and interferon-gamma receptor genes.
Eltayeb R; Mustafa M; Lycke N; van der Meide PH; Bakhiet M
Int J Mol Med; 1998 Jan; 1(1):177-83. PubMed ID: 9852217
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
[TBL] [Abstract][Full Text] [Related]
11. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.
Chen ZM; Li ZT; Li SQ; Guan WJ; Qiu Y; Lei ZY; Zhan YQ; Zhou H; Lin S; Wang X; Li Z; Yang F; Zeng W; Lin Y; Liu J; Zhang JQ; Ye F
BMC Infect Dis; 2021 Jun; 21(1):587. PubMed ID: 34144700
[TBL] [Abstract][Full Text] [Related]
12. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.
Chen LF; Yang CD; Cheng XB
Front Immunol; 2021; 12():788368. PubMed ID: 35003106
[TBL] [Abstract][Full Text] [Related]
13. The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity.
Chen PK; Yeo KJ; Chang SH; Liao TL; Chou CH; Lan JL; Chang CK; Chen DY
Virol J; 2023 Feb; 20(1):33. PubMed ID: 36810114
[TBL] [Abstract][Full Text] [Related]
14. Application of QuantiFERON ELISA for Detection of Interferon-Gamma Autoantibodies in Adult-Onset Immunodeficiency Syndrome.
Khositnithikul R; Laisuan W; Setthaudom C; Sriwanichrak K; Kunakorn M; Srikhirin T; Lumjiaktase P; Vongsakulyanon A
Lab Med; 2022 Jan; 53(1):12-17. PubMed ID: 34463313
[TBL] [Abstract][Full Text] [Related]
15. Recovery from Guillain-Barré syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma.
Elkarim RA; Dahle C; Mustafa M; Press R; Zou LP; Ekerfelt C; Ernerudh J; Link H; Bakhiet M
Clin Immunol Immunopathol; 1998 Sep; 88(3):241-8. PubMed ID: 9743610
[TBL] [Abstract][Full Text] [Related]
16. Levels of gamma interferon and interleukin-4 are inversely related to the levels of their corresponding autoantibodies in patients with lower respiratory tract infection.
ElKarim R; Granert C; Lindquist L; Link H; Bakhiet M
Infect Immun; 1999 Jun; 67(6):3051-4. PubMed ID: 10338519
[TBL] [Abstract][Full Text] [Related]
17. Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.
Cutrullis RA; Moscatelli GF; Moroni S; Volta BJ; Cardoni RL; Altcheh JM; Corral RS; Freilij HL; Petray PB
PLoS One; 2011; 6(10):e27133. PubMed ID: 22066031
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
[TBL] [Abstract][Full Text] [Related]
19. Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study.
Hetemäki I; Jian C; Laakso S; Mäkitie O; Pajari AM; de Vos WM; Arstila TP; Salonen A
Front Immunol; 2021; 12():668219. PubMed ID: 34367134
[TBL] [Abstract][Full Text] [Related]
20. Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies.
Akbil B; Meyer T; Stubbemann P; Thibeault C; Staudacher O; Niemeyer D; Jansen J; Mühlemann B; Doehn J; Tabeling C; Nusshag C; Hirzel C; Sanchez DS; Nieters A; Lother A; Duerschmied D; Schallner N; Lieberum JN; August D; Rieg S; Falcone V; Hengel H; Kölsch U; Unterwalder N; Hübner RH; Jones TC; Suttorp N; Drosten C; Warnatz K; Spinetti T; Schefold JC; Dörner T; Sander LE; Corman VM; Merle U; ; Kurth F; von Bernuth H; Meisel C; Goffinet C
J Clin Immunol; 2022 Aug; 42(6):1111-1129. PubMed ID: 35511314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
